16 May, EOD - Indian

SENSEX 82330.59 (-0.24)

Nifty 50 25019.8 (-0.17)

Nifty Bank 55354.9 (0.00)

Nifty IT 37972.35 (-0.84)

Nifty Midcap 100 57060.5 (0.94)

Nifty Next 50 67078.95 (1.29)

Nifty Pharma 21633.2 (-0.08)

Nifty Smallcap 100 17560.4 (1.86)

16 May, EOD - Global

NIKKEI 225 37584.25 (-0.45)

HANG SENG 23156.27 (-0.81)

S&P 5942 (-0.76)

LOGIN HERE
LOGIN HERE

companylogoInnova Captab Ltd

You are Here : Home > Markets > Company Information > Profit and Loss
BSE Code : 544067 | NSE Symbol : INNOVACAP | ISIN : INE0DUT01020 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
Profit and Loss
Particulars (₹ Cr)Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue From Operations 864.93858.67785.46410.66373.32
Sale of Products859.91853.50779.20406.85369.94
Sale of Services3.154.365.512.722.32
Income from Investment and Financial Services0.000.000.000.000.00
Income from Insurance Operations0.000.000.000.000.00
Other Operating Revenue1.870.810.741.101.06
Less: Excise Duty / GST0.000.000.000.000.00
Revenue From Operations - Net864.93858.67785.46410.66373.32
Other Income10.728.732.861.371.30
Total Revenue875.65867.41788.31412.03374.62
Changes in Inventories-1.35-1.481.001.64-7.76
Cost of Material Consumed640.47647.12573.64301.46288.69
Internally Manufactured Intermediates Consumed0.000.000.000.000.00
Purchases of Stock-in-Trade6.4021.6534.247.602.86
Employee Benefits50.1143.6037.3922.3320.24
Total Other Expenses 61.3349.2640.6823.1518.37
Manufacturing / Operating Expenses35.0228.3919.5710.739.85
Administrative and Selling Expenses19.7717.6615.549.467.61
Other Expenses6.543.215.572.960.91
Finance Costs13.5918.305.333.934.63
Depreciation and Amortization11.4010.667.405.5910.08
Total Expenses781.95789.10699.68365.69337.09
Profit Before Exceptional Items and Tax93.7078.3188.6346.3437.53
Exceptional Items Before Tax0.000.000.000.000.00
Profit Before Extraordinary Items and Tax93.7078.3188.6346.3437.53
Extraordinary Items Before Tax0.000.000.000.000.00
Other Adjustments Before Tax0.000.000.000.000.00
Profit Before Tax93.7078.3188.6346.3437.53
Taxation25.5420.7622.4611.849.64
Current Tax25.1818.8621.8011.509.25
MAT Credit Entitlement0.000.000.000.000.00
Deferred Tax0.351.890.660.350.40
Other Tax0.000.000.000.000.00
Adjust for Previous Year0.000.000.000.000.00
Profit After Tax68.1657.5566.1834.5027.89
Extraordinary Items After Tax0.000.000.000.000.00
Discontinued Operations After Tax0.000.000.000.000.00
Profit / (Loss) from Discontinuing Operations0.000.000.000.000.00
Tax Expenses of Discontinuing Operations0.000.000.000.000.00
Profit Attributable to Shareholders68.1657.5566.1834.5027.89
Adjustments to Net Income0.000.000.000.000.00
Preference Dividend0.000.000.000.000.00
Profit Attributable to Equity Shareholders68.1657.5566.1834.5027.89
Earning Per Share - Basic13.4811.9913.797.19232.38
Earning Per Share - Diluted13.4811.9913.797.19232.38

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +